
ALERNIL is a second generation selective non-sedating antihistamine indicated for the relief of symptoms associated with seasonal allergic rhinitis. It is a competitive peripheral selective histamine H1 receptor antagonist on effector cells in the GIT, blood vessels and the respiratory tract.
Login To Review